These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8962111)

  • 21. Evaluation of normal and neoplastic human mast cells for expression of CD172a (SIRPalpha), CD47, and SHP-1.
    Florian S; Ghannadan M; Mayerhofer M; Aichberger KJ; Hauswirth AW; Schernthaner GH; Printz D; Fritsch G; Böhm A; Sonneck K; Krauth MT; Müller MR; Sillaber C; Sperr WR; Bühring HJ; Valent P
    J Leukoc Biol; 2005 Jun; 77(6):984-92. PubMed ID: 15784688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of dominant-negative src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation.
    Dustin LB; Plas DR; Wong J; Hu YT; Soto C; Chan AC; Thomas ML
    J Immunol; 1999 Mar; 162(5):2717-24. PubMed ID: 10072516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antitumor activity of homoharringtonine against human mast cells harboring the KIT D816V mutation.
    Jin Y; Lu Z; Cao K; Zhu Y; Chen Q; Zhu F; Qian C; Pan J
    Mol Cancer Ther; 2010 Jan; 9(1):211-23. PubMed ID: 20053766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
    Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
    Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of interleukin-3-induced substrate phosphorylation and cell survival by SHP-2 (Src-homology protein tyrosine phosphatase 2).
    Wheadon H; Edmead C; Welham MJ
    Biochem J; 2003 Nov; 376(Pt 1):147-57. PubMed ID: 12935294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
    Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia.
    Beghini A; Ripamonti CB; Peterlongo P; Roversi G; Cairoli R; Morra E; Larizza L
    Hum Mol Genet; 2000 Sep; 9(15):2297-304. PubMed ID: 11001933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The scaffolding adapter Gab2, via Shp-2, regulates kit-evoked mast cell proliferation by activating the Rac/JNK pathway.
    Yu M; Luo J; Yang W; Wang Y; Mizuki M; Kanakura Y; Besmer P; Neel BG; Gu H
    J Biol Chem; 2006 Sep; 281(39):28615-26. PubMed ID: 16873377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3.
    Tsujimura T; Furitsu T; Morimoto M; Kanayama Y; Nomura S; Matsuzawa Y; Kitamura Y; Kanakura Y
    Int Arch Allergy Immunol; 1995 Apr; 106(4):377-85. PubMed ID: 7536501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The activation loop tyrosine 823 is essential for the transforming capacity of the c-Kit oncogenic mutant D816V.
    Agarwal S; Kazi JU; Mohlin S; Påhlman S; Rönnstrand L
    Oncogene; 2015 Aug; 34(35):4581-90. PubMed ID: 25435369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigations into the regulation and function of the SH2 domain-containing protein-tyrosine phosphatase, SHP-1.
    Tsui FW; Martin A; Wang J; Tsui HW
    Immunol Res; 2006; 35(1-2):127-36. PubMed ID: 17003515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The protein tyrosine kinase syk activity is reduced by clustering the mast cell function-associated antigen.
    Xu R; Pecht I
    Eur J Immunol; 2001 May; 31(5):1571-81. PubMed ID: 11465115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signal transduction of c-Kit receptor tyrosine kinase in CHRF myeloid leukemia cells.
    Scholl S; Kirsch C; Böhmer FD; Klinger R
    J Cancer Res Clin Oncol; 2004 Dec; 130(12):711-8. PubMed ID: 15340843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tyrosine phosphatase SHP-2 binding to CTLA-4: absence of direct YVKM/YFIP motif recognition.
    Schneider H; Rudd CE
    Biochem Biophys Res Commun; 2000 Mar; 269(1):279-83. PubMed ID: 10694513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p85 subunit of PI3 kinase does not bind to human Flt3 receptor, but associates with SHP2, SHIP, and a tyrosine-phosphorylated 100-kDa protein in Flt3 ligand-stimulated hematopoietic cells.
    Zhang S; Broxmeyer HE
    Biochem Biophys Res Commun; 1999 Jan; 254(2):440-5. PubMed ID: 9918857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Syk-independent tyrosine phosphorylation and association of the protein tyrosine phosphatases SHP-1 and SHP-2 with the high affinity IgE receptor.
    Kimura T; Zhang J; Sagawa K; Sakaguchi K; Appella E; Siraganian RP
    J Immunol; 1997 Nov; 159(9):4426-34. PubMed ID: 9379041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-2, but not IL-4 and other cytokines, induces phosphorylation of a 98-kDa protein associated with SHP-2, phosphatidylinositol 3'-kinase, and Grb2.
    Gadina M; Sudarshan C; O'Shea JJ
    J Immunol; 1999 Feb; 162(4):2081-6. PubMed ID: 9973481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PI3 kinase is indispensable for oncogenic transformation by the V560D mutant of c-Kit in a kinase-independent manner.
    Lindblad O; Kazi JU; Rönnstrand L; Sun J
    Cell Mol Life Sci; 2015 Nov; 72(22):4399-407. PubMed ID: 26040420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SRC-like adaptor protein 2 (SLAP2) is a negative regulator of KIT-D816V-mediated oncogenic transformation.
    Rupar K; Moharram SA; Kazi JU; Rönnstrand L
    Sci Rep; 2018 Apr; 8(1):6405. PubMed ID: 29686302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activating mutation in the catalytic domain of c-kit elicits hematopoietic transformation by receptor self-association not at the ligand-induced dimerization site.
    Tsujimura T; Hashimoto K; Kitayama H; Ikeda H; Sugahara H; Matsumura I; Kaisho T; Terada N; Kitamura Y; Kanakura Y
    Blood; 1999 Feb; 93(4):1319-29. PubMed ID: 9949175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.